CLTS — Earth Life Sciences Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.10m
- $0.15m
2017 December 31st | 2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | — | — | — | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.79 | 0.438 | 0.054 | 1.82 | 1.58 |
Operating Profit | -6.79 | -0.438 | -0.054 | -1.82 | -1.58 |
Net Income Before Taxes | -6.79 | -0.438 | -0.054 | -1.82 | -1.58 |
Net Income After Taxes | -6.79 | -0.438 | -0.054 | -1.82 | -1.58 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.79 | -0.438 | -0.054 | -1.82 | -1.58 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.79 | -0.438 | -0.054 | -1.82 | -1.58 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0.001 | -0 | -0.004 | -0.003 |